Logo image of ARHS

ARHAUS INC (ARHS) Stock Fundamental Analysis

NASDAQ:ARHS - US04035M1027 - Common Stock

12.41 USD
+0.54 (+4.55%)
Last: 8/22/2025, 8:00:00 PM
12.41 USD
0 (0%)
After Hours: 8/22/2025, 8:00:00 PM
Fundamental Rating

6

Overall ARHS gets a fundamental rating of 6 out of 10. We evaluated ARHS against 124 industry peers in the Specialty Retail industry. ARHS scores excellent on profitability, but there are some minor concerns on its financial health. ARHS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ARHS was profitable.
In the past year ARHS had a positive cash flow from operations.
Each year in the past 5 years ARHS has been profitable.
In the past 5 years ARHS always reported a positive cash flow from operatings.
ARHS Yearly Net Income VS EBIT VS OCF VS FCFARHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.40%, ARHS is in the better half of the industry, outperforming 69.35% of the companies in the same industry.
The Return On Equity of ARHS (18.46%) is better than 78.23% of its industry peers.
ARHS has a better Return On Invested Capital (7.65%) than 67.74% of its industry peers.
ARHS had an Average Return On Invested Capital over the past 3 years of 16.29%. This is above the industry average of 11.78%.
The 3 year average ROIC (16.29%) for ARHS is well above the current ROIC(7.65%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.4%
ROE 18.46%
ROIC 7.65%
ROA(3y)10.56%
ROA(5y)7.82%
ROE(3y)40.63%
ROE(5y)N/A
ROIC(3y)16.29%
ROIC(5y)17.01%
ARHS Yearly ROA, ROE, ROICARHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

ARHS's Profit Margin of 5.33% is fine compared to the rest of the industry. ARHS outperforms 78.23% of its industry peers.
ARHS's Profit Margin has improved in the last couple of years.
ARHS has a Operating Margin of 6.76%. This is in the better half of the industry: ARHS outperforms 75.00% of its industry peers.
ARHS's Operating Margin has improved in the last couple of years.
ARHS's Gross Margin of 39.34% is fine compared to the rest of the industry. ARHS outperforms 61.29% of its industry peers.
In the last couple of years the Gross Margin of ARHS has grown nicely.
Industry RankSector Rank
OM 6.76%
PM (TTM) 5.33%
GM 39.34%
OM growth 3Y16.64%
OM growth 5Y2.23%
PM growth 3Y26.76%
PM growth 5Y18.12%
GM growth 3Y-1.61%
GM growth 5Y2.07%
ARHS Yearly Profit, Operating, Gross MarginsARHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

ARHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, ARHS has more shares outstanding
Compared to 5 years ago, ARHS has more shares outstanding
The debt/assets ratio for ARHS has been reduced compared to a year ago.
ARHS Yearly Shares OutstandingARHS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M
ARHS Yearly Total Debt VS Total AssetsARHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ARHS has an Altman-Z score of 2.64. This is not the best score and indicates that ARHS is in the grey zone with still only limited risk for bankruptcy at the moment.
ARHS has a Altman-Z score (2.64) which is in line with its industry peers.
The Debt to FCF ratio of ARHS is 0.93, which is an excellent value as it means it would take ARHS, only 0.93 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 0.93, ARHS belongs to the best of the industry, outperforming 81.45% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that ARHS is not too dependend on debt financing.
The Debt to Equity ratio of ARHS (0.14) is better than 68.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.93
Altman-Z 2.64
ROIC/WACC0.81
WACC9.4%
ARHS Yearly LT Debt VS Equity VS FCFARHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ARHS has a Current Ratio of 1.33. This is a normal value and indicates that ARHS is financially healthy and should not expect problems in meeting its short term obligations.
ARHS has a Current ratio (1.33) which is comparable to the rest of the industry.
A Quick Ratio of 0.61 indicates that ARHS may have some problems paying its short term obligations.
The Quick ratio of ARHS (0.61) is comparable to the rest of the industry.
The current and quick ratio evaluation for ARHS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.61
ARHS Yearly Current Assets VS Current LiabilitesARHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The earnings per share for ARHS have decreased strongly by -20.63% in the last year.
ARHS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.52% yearly.
Looking at the last year, ARHS shows a small growth in Revenue. The Revenue has grown by 4.77% in the last year.
ARHS shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.78% yearly.
EPS 1Y (TTM)-20.63%
EPS 3Y48.09%
EPS 5Y43.52%
EPS Q2Q%56.25%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y16.84%
Revenue growth 5Y20.78%
Sales Q2Q%15.7%

3.2 Future

Based on estimates for the next years, ARHS will show a small growth in Earnings Per Share. The EPS will grow by 6.67% on average per year.
ARHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.58% yearly.
EPS Next Y-12.94%
EPS Next 2Y1.27%
EPS Next 3Y6.39%
EPS Next 5Y6.67%
Revenue Next Year5.1%
Revenue Next 2Y6.36%
Revenue Next 3Y6.97%
Revenue Next 5Y7.58%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ARHS Yearly Revenue VS EstimatesARHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
ARHS Yearly EPS VS EstimatesARHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.82, the valuation of ARHS can be described as rather expensive.
ARHS's Price/Earnings ratio is a bit cheaper when compared to the industry. ARHS is cheaper than 67.74% of the companies in the same industry.
ARHS's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.24.
Based on the Price/Forward Earnings ratio of 25.21, the valuation of ARHS can be described as expensive.
ARHS's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of ARHS to the average of the S&P500 Index (35.82), we can say ARHS is valued slightly cheaper.
Industry RankSector Rank
PE 24.82
Fwd PE 25.21
ARHS Price Earnings VS Forward Price EarningsARHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ARHS is valued a bit cheaper than 65.32% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARHS indicates a somewhat cheap valuation: ARHS is cheaper than 62.90% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 30.47
EV/EBITDA 8.57
ARHS Per share dataARHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

ARHS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.57
EPS Next 2Y1.27%
EPS Next 3Y6.39%

0

5. Dividend

5.1 Amount

No dividends for ARHS!.
Industry RankSector Rank
Dividend Yield N/A

ARHAUS INC

NASDAQ:ARHS (8/22/2025, 8:00:00 PM)

After market: 12.41 0 (0%)

12.41

+0.54 (+4.55%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners112.32%
Inst Owner Change-0.58%
Ins Owners5.31%
Ins Owner Change8.04%
Market Cap1.75B
Analysts75
Price Target10.07 (-18.86%)
Short Float %12.06%
Short Ratio3.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP0.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.91%
Min EPS beat(2)-36.28%
Max EPS beat(2)64.1%
EPS beat(4)2
Avg EPS beat(4)5.84%
Min EPS beat(4)-36.28%
Max EPS beat(4)64.1%
EPS beat(8)6
Avg EPS beat(8)78.22%
EPS beat(12)10
Avg EPS beat(12)67.47%
EPS beat(16)14
Avg EPS beat(16)74.98%
Revenue beat(2)1
Avg Revenue beat(2)1.16%
Min Revenue beat(2)-3%
Max Revenue beat(2)5.32%
Revenue beat(4)1
Avg Revenue beat(4)-1.45%
Min Revenue beat(4)-4.97%
Max Revenue beat(4)5.32%
Revenue beat(8)4
Avg Revenue beat(8)0.22%
Revenue beat(12)6
Avg Revenue beat(12)0.02%
Revenue beat(16)9
Avg Revenue beat(16)1.87%
PT rev (1m)0%
PT rev (3m)-12.97%
EPS NQ rev (1m)6.08%
EPS NQ rev (3m)-18.41%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.56%
Revenue NQ rev (1m)1.2%
Revenue NQ rev (3m)-3.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 24.82
Fwd PE 25.21
P/S 1.31
P/FCF 30.47
P/OCF 12.13
P/B 4.54
P/tB 4.67
EV/EBITDA 8.57
EPS(TTM)0.5
EY4.03%
EPS(NY)0.49
Fwd EY3.97%
FCF(TTM)0.41
FCFY3.28%
OCF(TTM)1.02
OCFY8.25%
SpS9.48
BVpS2.74
TBVpS2.66
PEG (NY)N/A
PEG (5Y)0.57
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 18.46%
ROCE 10.23%
ROIC 7.65%
ROICexc 10.42%
ROICexgc 10.6%
OM 6.76%
PM (TTM) 5.33%
GM 39.34%
FCFM 4.3%
ROA(3y)10.56%
ROA(5y)7.82%
ROE(3y)40.63%
ROE(5y)N/A
ROIC(3y)16.29%
ROIC(5y)17.01%
ROICexc(3y)22.28%
ROICexc(5y)30.4%
ROICexgc(3y)22.81%
ROICexgc(5y)34.8%
ROCE(3y)21.77%
ROCE(5y)22.73%
ROICexcg growth 3Y-40.08%
ROICexcg growth 5Y-10.67%
ROICexc growth 3Y-36.41%
ROICexc growth 5Y-9.4%
OM growth 3Y16.64%
OM growth 5Y2.23%
PM growth 3Y26.76%
PM growth 5Y18.12%
GM growth 3Y-1.61%
GM growth 5Y2.07%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.93
Debt/EBITDA 0.3
Cap/Depr 103.79%
Cap/Sales 6.5%
Interest Coverage 17.93
Cash Conversion 82.88%
Profit Quality 80.66%
Current Ratio 1.33
Quick Ratio 0.61
Altman-Z 2.64
F-Score5
WACC9.4%
ROIC/WACC0.81
Cap/Depr(3y)167.27%
Cap/Depr(5y)155.74%
Cap/Sales(3y)6.66%
Cap/Sales(5y)5.71%
Profit Quality(3y)44.67%
Profit Quality(5y)347.09%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.63%
EPS 3Y48.09%
EPS 5Y43.52%
EPS Q2Q%56.25%
EPS Next Y-12.94%
EPS Next 2Y1.27%
EPS Next 3Y6.39%
EPS Next 5Y6.67%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y16.84%
Revenue growth 5Y20.78%
Sales Q2Q%15.7%
Revenue Next Year5.1%
Revenue Next 2Y6.36%
Revenue Next 3Y6.97%
Revenue Next 5Y7.58%
EBIT growth 1Y-19.78%
EBIT growth 3Y36.28%
EBIT growth 5Y23.47%
EBIT Next Year61.11%
EBIT Next 3Y27.47%
EBIT Next 5Y21.19%
FCF growth 1Y90.69%
FCF growth 3Y-26.06%
FCF growth 5Y27.06%
OCF growth 1Y51.51%
OCF growth 3Y0.21%
OCF growth 5Y46.37%